Powered by: Motilal Oswal
2026-09-25 09:06:47 am | Source: Motilal Oswal Financial Services Ltd
Buy Niva Bupa Health Insurance Ltd for the Target Rs 100 by Motilal Oswal Financial Services Ltd
Buy Niva Bupa Health Insurance Ltd for the Target Rs 100 by Motilal Oswal Financial Services Ltd

Distribution reforms positive; minor impact on nearterm growth

Niva Bupa hosted a conference call to discuss the implications of the consultation paper released on distribution regulations. The company believes that the measures in the draft would be a net positive for the industry and the company. We concur with the view that the measures are positive over the medium term, whereas in the shorter term, the industry will reassess product constructs and distribution architectures, which could weigh on growth. We maintain our estimates and retain BUY rating with a one-year TP of INR100

Key takeaways:

Management called the IRDAI distribution consultation paper a net positive for the industry and the company.

* Retail health (~75% of Q1 book) – positive. Lower commissions let the company hold prices flat for longer, as it did after the GST exemption. Volumes should offset lower rates for distributors.

* Agency – positive. Proposed 20% first-year/10% renewal cap is close to what the company already pays.

* Banca – positive on growth and economics, despite a sharper cut. ? Precedent: After the GST ITC loss, monthly retail business from banks doubled in 12 months.

* Digital brokers (Policybazaar) – positive for the insurer's economics. Growth is expected to stay strong; final commission level is still open.

* Group/B2B (~8% of book) – neutral to marginally positive. Pricing cycle is the bigger lever.

* Credit-linked business (~15% of FY26 GWP) – the one negative. Volumes will drop; mitigants are new lender counters and a signed MoU with a life insurer for a composite term + credit life + health offering.

* EOM: Confident of reaching 25% of GWP in two years (from ~34-35%) and ~20% in five years.

* Combined ratio: Reform accelerates the path to the 98-99% target; formal guidance review after 2QFY27 results. Long-run ROE target of 15-18% is unchanged.

Other key points

* Renewals/grandfathering: Management's reading is that new rates apply to all in-force business renewing after implementation, not only new business. A policy written in FY27 and renewed in FY28 would pay the new rate. The company will seek IRDAI clarity. If it turns out to be prospective only, the EOM path would need rework.

* Channel-specific pricing: Differential pricing by channel is already allowed; the company chooses uniform pricing. The proposed commission is a cap, not a floor, so quality-linked incentives can still vary within it. Customer quality is controlled mainly through underwriting.

* Direct-to-consumer: Direct still costs about 10pp less than intermediated business, so it remains more attractive. Customer ownership value is unchanged and DTC investment continues.

 

For More Research Reports : Click Here 

For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here